Sep 29

QP 28 - Actionable Biomarkers: Guiding Therapy Selection and De-escalation

1168 - Germline Biomarker Predicts Adverse Events following SBRT to the Prostate Fossa after Radical Prostatectomy

05:45pm - 05:50pm ET

Presenter(s)

Joanne Weidhaas, MD, PhD - UCLA Radiation Oncology, Los Angeles, CA